15930-60-6

Basic information

• Product Name: Benzamide, N,N-diethyl-3-iodo-
• CAS NO: 15930-60-6
• Molecular Formula: C11H14INO
• Molecular Weight: 303.143
• Mol File: 15930-60-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzamide, N,N-diethyl-3-iodo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, N,N-diethyl-3-iodo-(15930-60-6)
• EPA Substance Registry System: Benzamide, N,N-diethyl-3-iodo-(15930-60-6)

Safety Data

• Hazardous Substances Data: 15930-60-6(Hazardous Substances Data)

Upstream product

• 1711-10-0 3-iodobenzoyl chloride 
• 109-89-7 diethylamine 
• 626-01-7 3-Iodoaniline 
• 201230-82-2 carbon monoxide 
• 425436-17-5 3,3-diethyl-1-(3-iodophenyl)triaz-1-ene 
• 79-37-8 oxalyl dichloride 
• 618-51-9 3-Iodobenzoic acid 

Downstream Products

• 929042-14-8 N,N-diethyl-3-(3-methoxyphenylthiocarbamoyl)benzamide 
• 1439984-80-1 (R)-2-(1-(3-N,N-diethylaminocarbonylphenyl)vinyl)tetrahydrofuran 
• 1351684-32-6 3,3'-{3,3'-[ethane-1,2-diyl-bis(azanediyl)]bis(propane-3,1-diyl)}bis(azanediyl)bis(N,N-diethylbenzamide) 
• 1351684-34-8 3,3'-{3,3'-[2,2'-oxybis(ethane-2,1-diyl)bis(oxy)]bis(propane-3,1-diyl)}bis(azanediyl)bis(N,N-diethylbenzamide) 
• 1351684-35-9 3,3'-{2,2'-[ethane-1,2-diyl-bis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(N,N-diethylbenzamide) 
• 1351684-33-7 3,3'-[3,3'-azanediyl-bis(propane-3,1-diyl)bis(azanediyl)]bis(N,N-diethylbenzamide) 

Relevant articles and documents

N2 extrusion and co insertion: A novel palladium-catalyzed carbonylative transformation of aryltriazenes

A novel procedure for the replacement of N2 with CO of aryltriazenes has been developed. Aryltriazenes were converted to the corresponding arylamides catalyzed by 1 mol % of PdCl2/P(o-Tol)3 under CO pressure. In this process, aryldiazonium salts were generated in the presence of 40 mol % of MeSO3H. Nitrogen was released from the substrates and CO formally inserted. Aryl bromides, iodides, alkynes, and free hydroxyl groups can be tolerated in this transformation.

OPIOID COMPOUNDS

Diarylmethyl piperazine compounds having utility as exogenous receptor combinant species for binding with receptors such as delta, mu, sigma, and/or kappa receptors are disclosed. Compounds of the invention may be employed as conjugates in agonist/antagonist pairs for transductional monitoring and assays of neurotransmitter function, and also variously exhibit therapeutic utility, including mediating analgesia, and possessing utility for the treatment of diarrhea, urinary incontinence, mental illness, drug and alcohol addiction/overdose, lung edema, depression, asthma, emphysema, cough, and apnea, respiratory depression, cognitive disorders, emesis and gastrointestinal disorders.